Fluidigm Corp. (FLDM)

[biffbifford]

It's not that the market didn't like the news; it has to do with exposure. Until we get the approval, the next 3-weeks to a month will see the positioning of investors familiar to this sector. The excellent news is we broke above the liquidation channel, driven by a moderate amount of enthusiasm.
$4.27 is resistance, and if we break that, the next resistance point is $5.25. But until the official word comes in from the FDA, don't be surprised if we go into the weekend still under $4.00 a share, and why not, without exposure there is still time to accumulate at a better price (so thinketh potential investors). Our time will come, and my short term prediction is (2-3 months) just above $6.00 a share with a year-end price target of $10.00+

Of course, just my opinions.

Best,

Biff